Inhibition of MHC‐I by Brucella abortus is an early event during infection and involves EGFR pathway
- 29 November 2016
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 95 (4) , 388-398
Abstract
Brucella abortus is able to persist inside the host despite the development of potent CD8+ T cell responses. We have recently reported the ability of B. abortus to inhibit the IFN-γ-induced MHC-I cell surface expression on human monocytes. This phenomenon was due to the B. abortus-mediated retention of MHC-I molecules within the Golgi apparatus and was dependent on bacterial viability. However, the implications of bacterial virulence or replicative capacity and the signaling pathways remained unknown. Here, we demonstrated that the B. abortus mutant strains RB51 and virB10− are able to inhibit MHC-I expression in the same manner as wild type B. abortus, even though they are unable to persist inside human monocytes for a long period of time. Consistent with this, the phenomenon was triggered early in time and could be observed at 8 h post-infection. At 24 and 48 h it was even stronger. Regarding the signaling pathway, targeting EGF receptor (EGFR), ErbB2 (HER2) or inhibition of TACE, one of the enzymes which generates soluble EGF-like ligands, resulted in partial recovery of MHC-I surface expression. Moreover, recombinant EGF and TGF-α as well as the combination of both were also able to reproduce the B. abortus-induced MHC-I down-modulation. Finally, when infection was performed in the presence of an Erk1/2 inhibitor, MHC-I surface expression was significantly recovered. Overall, these results describe how B. abortus evades CD8+ T cell responses early during infection and exploits the EGFR-ERK signaling pathway to escape from the immune system and favor chronicity.Keywords
Funding Information
- Fundación Alberto J. Roemmers (2012–2014)
This publication has 49 references indexed in Scilit:
- Type IV secretion system of Brucella spp. and its effectorsFrontiers in Cellular and Infection Microbiology, 2015
- Sleeping with the Enemy: How Intracellular Pathogens Cope with a Macrophage LifestylePLOS Pathogens, 2012
- Epidermal Growth Factor Receptor Inhibition Augments the Expression of MHC Class I and II GenesClinical Cancer Research, 2011
- MHC class I antigen presentation: learning from viral evasion strategiesNature Reviews Immunology, 2009
- Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epitheliumAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Interferon gamma‐dependent transactivation of epidermal growth factor receptorFEBS Letters, 2007
- Surviving inside a macrophage: The many ways of BrucellaResearch in Microbiology, 2006
- Lipoproteins, Not Lipopolysaccharide, Are the Key Mediators of the Proinflammatory Response Elicited by Heat-Killed Brucella abortusThe Journal of Immunology, 2004
- BrucellaEvades Macrophage Killing via VirB-dependent Sustained Interactions with the Endoplasmic ReticulumJournal of Experimental Medicine, 2003
- The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surfaceOncogene, 2002